Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2015.
The company has reported over three fold jump in its net profit at Rs 280.13 crore for the quarter ended December 31, 2015 as compared to Rs 73.99 crore for the same quarter in the previous year. The company’s total income has increased by 79.33% to Rs 900.49 crore for the quarter under review from Rs 502.15 crore for the corresponding quarter of the previous year.
On the consolidated basis, the company has reported over three fold jump in its net profit after tax and minority interest nd Share of Profit / (Loss) of Associates of Rs 269.49 crore for the quarter ended December 31, 2015 as compared to Rs 70.66 crore for the same quarter in the previous year. Total income of the company has increased by 80.60% at Rs 924.53 crore for quarter under review as compared to Rs 511.91 crore for the quarter ended December 31, 2014.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |